PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation

Published:2021 Issue:4 Volume:9 Page:1246-1255
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Yang Min¹²³⁴^ORCID,Xu Zhanxue¹²³⁴^ORCID,Yan Hailan¹²³⁴^ORCID,Tsai Hsiang-i¹²³⁴^ORCID,Su Dandan¹²³⁴^ORCID,Yan Fuxia¹²³⁴^ORCID,Lu Qiumei¹²³⁴^ORCID,Feng Jianhua⁵⁶⁷⁸⁴^ORCID,Zeng Weiwei¹²³⁴^ORCID,Xi Lifang¹²³⁴^ORCID,Zha Hualian¹²³⁴^ORCID,Ling Yunzhi¹²³⁴^ORCID,He Chao¹²³⁴^ORCID,Wu Yingyi¹²³⁴^ORCID,Xu Xiaowei⁹¹⁰³⁴^ORCID,Zheng Gang¹¹¹²⁴^ORCID,Liu Gan¹²³⁴^ORCID,Chen Hongbo¹²³⁴^ORCID,Cheng Fang¹²³⁴^ORCID

Affiliation:

1. School of Pharmaceutical Sciences (Shenzhen)

2. Sun Yat-sen University

3. Shenzhen

4. China

5. Department of Hematology

6. Zhujiang Hospital

7. Southern Medical University

8. Guangzhou

9. Clinical Neuroscience Center

10. The Seventh Affiliated Hospital of Sun Yat-sen University

11. XuZhou Central Hospital Affiliated to Medical School of Southeast University

12. XuZhou

Abstract

PD-L1 nanovesicles carrying rapamycin inhibit T cell activation to promote allograft acceptance.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Medical Science and Technology Foundation of Guangdong Province

Science, Technology and Innovation Commission of Shenzhen Municipality

Sun Yat-sen University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D0BM01798A

Reference37 articles.

1. Advances in diagnostics for transplant rejection

2. Imaging transplant rejection: a new view

3. Organ transplantation—how much of the promise has been realized?

4. Immunosuppressive Medications

5. Overview of Immunosuppressive Therapy in Solid Organ Transplantation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection;Advanced Materials;2024-07

2. Genetically Engineered Cellular Nanovesicles: Theories, Design and Perspective;Advanced Functional Materials;2024-07

3. Immune checkpoint molecules in solid organ transplantation: A promising way to prevent rejection;Immunology Letters;2024-06

4. TRAF6 enhances PD-L1 expression through YAP1-TFCP2 signaling in melanoma;Cancer Letters;2024-05

5. Nanoparticle-assisted Targeting Delivery Technologies for Preventing Organ Rejection;Transplantation;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3